| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), MBIO's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.6K | $1.2K | - | |
| Dir | 375 | $358.05 | - | |
| Dir | 286 | $275.13 | - | |
| Dir | 145 | $139.49 | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Chill Adam J. | Director | Sell | 4 | $0.95 | $3.82 | -1.1% | -23.7% | - | |
| Dec 30, 2025 | Herskowitz Neil | Director | Sell | 247 | $0.96 | $237.61 | -63.0% | -23.7% | - | |
| Dec 30, 2025 | Jin David | Director | Buy | 247 | $0.96 | $237.61 | +633.3% | -23.7% | - | |
| Sep 13, 2022 | Litchman Manuel Md | Director | Buy | 10,000 | $0.63 | $6,277.00 | +0.9% | -28.8% | -70.6% | |
| Sep 13, 2022 | Rosenwald Lindsay A Md64 | Director | Buy | 9,094 | $0.62 | $5,607.47 | +3.1% | -28.8% | -70.6% | |
| Dec 14, 2021 | Achenbach Brian78 | SVP, Fin. &Corp. Controller | Sell | 4,374 | $1.83 | $8,004.42 | -2.9% | -59.9% | -78.2% | |
| Oct 27, 2021 | Litchman Manuel Md | President And CEO | Buy | 65,000 | $2.24 | $145,600.00 | +6.7% | -45.0% | -76.8% | |
| Oct 12, 2021 | Achenbach Brian78 | SVP, Fin. &Corp. Controller | Sell | 4,450 | $2.28 | $10,146.00 | -3.4% | -30.9% | -79.0% | |
| Jul 30, 2021 | Litchman Manuel Md | President And CEO | Buy | 86,206 | $2.91 | $250,859.46 | +9.9% | -21.8% | -79.9% | |
| Apr 9, 2021 | Achenbach Brian78 | SVP, Fin. &Corp. Controller | Sell | 20,721 | $3.20 | $66,281.83 | -13.7% | -3.8% | -68.3% |